169 related articles for article (PubMed ID: 12727817)
1. Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities.
Koh E; Clair T; Woodhouse EC; Schiffmann E; Liotta L; Stracke M
Cancer Res; 2003 May; 63(9):2042-5. PubMed ID: 12727817
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D.
Jansen S; Stefan C; Creemers JW; Waelkens E; Van Eynde A; Stalmans W; Bollen M
J Cell Sci; 2005 Jul; 118(Pt 14):3081-9. PubMed ID: 15985467
[TBL] [Abstract][Full Text] [Related]
3. Expression and transcriptional regulation of the PD-Ialpha/autotaxin gene in neuroblastoma.
Kawagoe H; Stracke ML; Nakamura H; Sano K
Cancer Res; 1997 Jun; 57(12):2516-21. PubMed ID: 9192834
[TBL] [Abstract][Full Text] [Related]
4. Lysophospholipids in the limelight: autotaxin takes center stage.
Moolenaar WH
J Cell Biol; 2002 Jul; 158(2):197-9. PubMed ID: 12135981
[TBL] [Abstract][Full Text] [Related]
5. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate.
Clair T; Aoki J; Koh E; Bandle RW; Nam SW; Ptaszynska MM; Mills GB; Schiffmann E; Liotta LA; Stracke ML
Cancer Res; 2003 Sep; 63(17):5446-53. PubMed ID: 14500380
[TBL] [Abstract][Full Text] [Related]
6. Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun.
Black EJ; Clair T; Delrow J; Neiman P; Gillespie DA
Oncogene; 2004 Mar; 23(13):2357-66. PubMed ID: 14691447
[TBL] [Abstract][Full Text] [Related]
7. Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells.
Nam SW; Clair T; Campo CK; Lee HY; Liotta LA; Stracke ML
Oncogene; 2000 Jan; 19(2):241-7. PubMed ID: 10645002
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin.
Lee HY; Clair T; Mulvaney PT; Woodhouse EC; Aznavoorian S; Liotta LA; Stracke ML
J Biol Chem; 1996 Oct; 271(40):24408-12. PubMed ID: 8798697
[TBL] [Abstract][Full Text] [Related]
9. The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site.
Gijsbers R; Aoki J; Arai H; Bollen M
FEBS Lett; 2003 Mar; 538(1-3):60-4. PubMed ID: 12633853
[TBL] [Abstract][Full Text] [Related]
10. Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2.
Cimpean A; Stefan C; Gijsbers R; Stalmans W; Bollen M
Biochem J; 2004 Jul; 381(Pt 1):71-7. PubMed ID: 15096095
[TBL] [Abstract][Full Text] [Related]
11. Secretion and lysophospholipase D activity of autotaxin by adipocytes are controlled by N-glycosylation and signal peptidase.
Pradère JP; Tarnus E; Grès S; Valet P; Saulnier-Blache JS
Biochim Biophys Acta; 2007 Jan; 1771(1):93-102. PubMed ID: 17208043
[TBL] [Abstract][Full Text] [Related]
12. A sensitive screening assay for secreted motility-stimulating factors.
Nam SW; Clair T; Schiffmann E; Liotta LA; Stracke ML
Cell Motil Cytoskeleton; 2000 Aug; 46(4):279-84. PubMed ID: 10962482
[TBL] [Abstract][Full Text] [Related]
13. Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression.
Boucher J; Quilliot D; Pradères JP; Simon MF; Grès S; Guigné C; Prévot D; Ferry G; Boutin JA; Carpéné C; Valet P; Saulnier-Blache JS
Diabetologia; 2005 Mar; 48(3):569-77. PubMed ID: 15700135
[TBL] [Abstract][Full Text] [Related]
14. Expression, regulation and function of autotaxin in thyroid carcinomas.
Kehlen A; Englert N; Seifert A; Klonisch T; Dralle H; Langner J; Hoang-Vu C
Int J Cancer; 2004 May; 109(6):833-8. PubMed ID: 15027116
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.
van Meeteren LA; Ruurs P; Christodoulou E; Goding JW; Takakusa H; Kikuchi K; Perrakis A; Nagano T; Moolenaar WH
J Biol Chem; 2005 Jun; 280(22):21155-61. PubMed ID: 15769751
[TBL] [Abstract][Full Text] [Related]
16. Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate.
Song J; Clair T; Noh JH; Eun JW; Ryu SY; Lee SN; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Nam SW
Biochem Biophys Res Commun; 2005 Nov; 337(3):967-75. PubMed ID: 16219296
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic activation of autotaxin by divalent cations without EF-hand loop region involvement.
Lee J; Jung ID; Nam SW; Clair T; Jeong EM; Hong SY; Han JW; Lee HW; Stracke ML; Lee HY
Biochem Pharmacol; 2001 Jul; 62(2):219-24. PubMed ID: 11389881
[TBL] [Abstract][Full Text] [Related]
18. Nucleotide binding to autotaxin: crosslinking of bound substrate followed by lysC digestion identifies two labeled peptides.
Clair T; Krutzsch HC; Liotta LA; Stracke ML
Biochem Biophys Res Commun; 1997 Jul; 236(2):449-54. PubMed ID: 9240459
[TBL] [Abstract][Full Text] [Related]
19. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor.
Nam SW; Clair T; Kim YS; McMarlin A; Schiffmann E; Liotta LA; Stracke ML
Cancer Res; 2001 Sep; 61(18):6938-44. PubMed ID: 11559573
[TBL] [Abstract][Full Text] [Related]
20. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
Umezu-Goto M; Kishi Y; Taira A; Hama K; Dohmae N; Takio K; Yamori T; Mills GB; Inoue K; Aoki J; Arai H
J Cell Biol; 2002 Jul; 158(2):227-33. PubMed ID: 12119361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
